Kardigan, Inc. (KARD)
NASDAQ · Healthcare
$21.40+1.28%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $1.89B
- P/E ratio
- —
- EPS
- —
- Volume
- 329,831
- 52-week high
- —
- 52-week low
- —
- Open
- $21.30
- Day high
- $22.05
- Day low
- $20.75
Financial highlights
Annual financials for Kardigan, Inc. are being compiled and will appear here soon.
About Kardigan, Inc.
Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.
- CEO
- Tassos Gianakakos
- Employees
- 241
- Country
- US
- IPO date
- Jun 18, 2026
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Kardigan, Inc.'s stock price today?
- KARD is trading at $21.40 as of Jul 20, 2026.
- What is Kardigan, Inc.'s market cap?
- Kardigan, Inc. (KARD) has a market capitalization of $1.89B.
- What sector is Kardigan, Inc. in?
- Kardigan, Inc. operates in the Healthcare sector.